BICO Group AB is a bio-convergence company... Show more
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
CLLKF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on August 12, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CLLKF as a result. In of 65 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CLLKF turned negative on August 13, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 34 similar instances when the indicator turned negative. In of the 34 cases the stock turned lower in the days that followed. This puts the odds of success at .
CLLKF moved below its 50-day moving average on August 19, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CLLKF crossed bearishly below the 50-day moving average on August 19, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The Aroon Indicator for CLLKF entered a downward trend on September 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.698) is normal, around the industry mean (60.094). P/E Ratio (0.000) is within average values for comparable stocks, (37.985). CLLKF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.647). CLLKF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (0.999) is also within normal values, averaging (56.312).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CLLKF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLLKF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Industry MedicalNursingServices
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IASMX | 19.05 | 0.29 | +1.55% |
Guinness Atkinson Asia Focus | |||
GOFCX | 27.91 | 0.33 | +1.20% |
Victory Pioneer Select Mid Cap Growth C | |||
HLMGX | 36.94 | 0.26 | +0.71% |
Harding Loevner Global Equity Advisor | |||
SCSIX | 43.16 | 0.08 | +0.19% |
Sterling Capital SmCp Val R6 | |||
JEPAX | 14.12 | N/A | N/A |
JPMorgan Equity Premium Income A |
A.I.dvisor tells us that CLLKF and FONR have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLLKF and FONR's prices will move in lockstep.
Ticker / NAME | Correlation To CLLKF | 1D Price Change % | ||
---|---|---|---|---|
CLLKF | 100% | N/A | ||
FONR - CLLKF | 29% Poorly correlated | N/A | ||
TPGVF - CLLKF | 20% Poorly correlated | N/A | ||
LUNG - CLLKF | 10% Poorly correlated | -2.30% | ||
SHC - CLLKF | 9% Poorly correlated | +1.86% | ||
BDSX - CLLKF | 7% Poorly correlated | -2.08% | ||
More |
Ticker / NAME | Correlation To CLLKF | 1D Price Change % |
---|---|---|
CLLKF | 100% | N/A |
Health Services category (439 stocks) | 4% Poorly correlated | -0.59% |
Medical/Nursing Services category (226 stocks) | -2% Poorly correlated | -0.58% |